RWE Masterclass 4: ‘Individualizing Benefit Risk’ Session 4: ‘Individualizing Benefit Risk’, will take place on Wednesday, 16 June 2021 at 5 pm CEST MORE INFORMATION|REGISTER HERE SUMMARY: Conventional methods of benefit-risk overly focus on overall results; subgroups have limitations, and the relative importance of events may not be considered. Individualizing benefit-risk more precisely would…
Read more
RWE Masterclass 3: ‘Non-randomised comparative studies’ Non-randomised comparative studies will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are meant for attendees to learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist and statistician, and…
Read more
RWE Live Masterclass 2: ‘The Tyranny of Propensity Scores’ Propensity Scores will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are meant for attendees to learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist…
Read more
Real-World Evidence & Trials Masterclass Series 2021 OXON Epidemiology will be hosting a Real-World Evidence Masterclass Series for all professionals interested in learning about the role of Real-World Data studies and their pros and cons compared with trials. Real-World Evidence (RWE) is a key opportunity to better understand the diseases and patient needs. Besides, all…
Read more
OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.
Understanding Health Care in Germany is our upcoming webinar. Registration is open for professionals in Pharma companies willing to learn about how to conduct observational studies in this scenario.
The Nordics is within OXON’s 2019/20 webinar series to help understand health care for conducting optimal observational studies.
22nd – 23rd May 2019,
Holiday Inn London Kensington Hotel, London UK
Nawab Qizilbash, Head of OXON, will be speaking about PASS Studies.
The third of OXON’s webinar series from leading national pharmaco-epidemiologists spread over many months to provide a phased educational experience to learn about health care for conducting optimal observational studies.
The second of OXON’s webinar series from leading national pharmaco-epidemiologists spread over many months to provide a phased educational experience to learn about health care for conducting optimal observational studies.
